Cardiovascular Implantable Electronic Devices in Hemodialysis Patients: Prevalence and Implications for Arteriovenous Hemodialysis Access Interventions

Seminars in Dialysis

Volumn 28, Issue 1, 2015, Pages 94-100

  Saad, Theodore F ^a,b   Ahmed, Waqas ^a,b   Davis, Karen ^a   Jurkovitz, Claudine ^b  

^a Nephrology Associates   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERIOVENOUS SHUNT; ARTIFICIAL HEART PACEMAKER; BRACHIOCEPHALIC VEIN; COMPLICATION; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SUBCLAVIAN VEIN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BRACHIOCEPHALIC VEINS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SUBCLAVIAN VEIN;

EID: 84920848450     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12249     Document Type: Article

References (34)

1. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010. Cardiovascular special studies; defibrillators. 338-339
2. Charytan DM, Patrick AM, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC: Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 58:409-417, 2011
3. Drew DA, Myers KB, Weiner DE: Transvenous cardiac device wires and vascular access in hemodialysis patients. Am J Kidney Dis 58:494-495, 2011
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilbur DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883, 2002
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237, 2005
6. Desai AS, Fang JC, Maisel WH, Baughman KL: Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292:2874-2879, 2004
7. The antiarrhythmics versus implantable defibrillators (AVID) investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576-1583, 1997
8. Cuculich P, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva ME, Smith TW, Lindsay BD: Poor Prognosis for Patients with Chronic Kidney Disease Despite ICD Therapy for the Primary Prevention of Sudden Death. Pacing Clin Electrophysiol 30:207-213, 2007
9. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R: Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardiac defibrillator recipients. Heart Rhythm 3:1196-1201, 2006
10. Koplan BA, Epstein LM, Albert CM, Stevenson WG: Survival in octogenarians receiving implantable defibrillators. Am Heart J 152:714-719, 2006
11. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT: Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68:818-825, 2005
12. Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidnereich PA: Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 6:1565-1571, 2009
13. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Golberger J, Passman R: Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 49:656-663, 2007
14. Lam N, Leong-Sit P, Garg AX: The role of implantable cardioverter-defibrillators in long-term dialysis patients. Am J Kidney Dis 58:338-339, 2011
15. Epstein AE, DiMarco JP, Ellenbogen KA, Estes M, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 117:e350-e408, 2008
16. Teruya TH, Abou-Zamzam AM, Limm W, Wong L, Wong L: Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 17:526-529, 2003
17. NKF-K/DOQI: Clinical practice guidelines for vascular access update 2000. Am J Kidney Dis 37:S137-S181, 2001
18. NKF-K/DOQI: Clinical practice guidelines for vascular access update 2006. Am J Kidney Dis 48(Suppl. 1):S177-S247, 2006
19. Tan CS, Jie C, Joe J, Irani ZD, Ganguli S, Kalva SP, Wicky S, Wu S: The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients. Semin Dial 26:728-732, 2013
20. Saad TF, Myers GR, Cicone JS: Central vein stenosis or occlusion associated with cardiac rhythm management device leads in hemodialysis patients with ipsilateral arteriovenous access: A retrospective study of treatment using stents or stent-grafts. J Vasc Access 11:293-302, 2010
21. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA: Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace 9:328-332, 2007
22. DaCosta SS, Neto AS, Costa R, Caldas JG, Filho MM: Incidence and risk factors of upper extremity deep vein lesion after permanent transvenous pacemaker implant: A 6-month follow-up prospective study. Pacing Clin Electrophysiol 25:1301-1306, 2002
23. Deighan CJ, McLaughlin KJ, Simipson K, Boulton Jones JM: Unsuspected subclavian stenosis resulting from a permanent pacing wire. Nephrol Dial Transplant 11:2333-2334, 1996
24. Korzets A, Chagnac A, Ori Y, Katz M, Zevin D: Subclavian vein stenosis, permanent cardiac pacemakers and the haemodialysed patient. Nephron 58:103-105, 1991
25. Tourret J, Cluzel P, Tostivint I, Barrou B, Deray G, Bagnis CI: Central venous stenosis as a complication of ipsilateral haemodialysis fistula and pacemaker. Nephrol Dial Transplant 20:997-1001, 2005
26. Chuang CL, Tarng DC, Yang WC, Huang TP: An occult cause of arteriovenous access failure: central vein stenosis from permanent pacemaker wire. Report of three cases and review of the literature. Am J Nephrol 21:406-409, 2001
27. Asif A, Salman L, Carrillo RG, Garisto JD, Lopera G, Barakat U, Lenz O, Yevzlin A, Agarwal A, Gadalean F, Sachdeva B, Vachharajani TJ, Wu S, Maya ID, Abreo K: Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study. Semin Dial 22:671-676, 2009
28. Allon M: Current Management of Vascular Access. Clin J Am Soc Nephrol 2:786-800, 2007
29. Bolad I, Karanam S, Mathew D, John R, Piemonte T, Martin D: Percutaneous treatment of superior vena cava obstruction following transvenous device implantation. Catheter Cardiovasc Interv 65:54-59, 2005
30. Chamorro H, Rao G, Wholey MH: Superior vena cava syndrome: A complication of transvenous pacemaker implantation. Radiology 126:377-378, 1978
31. Goudvenous JA, Reid PG, Adams PC, Holden MP, Williams DO: Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol 12:1890-1895, 1989
32. Asif A, Carrillo R, Garisto JD, Lopera G, Ladino M, Barakat U, Eid N, Salman L: Epicardial Cardiac Rhythm Devices for Dialysis Patients: Minimizing the Risk of Infection and Preserving Central Veins. Semin Dial 25:88-94, 2012
33. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA: An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363:36-44, 2010
34. Crozier I: The subcutaneous defibrillator will replace the transvenous defibrillator. J Interv Card Electrophysiol 32:73-77, 2011